Financial Services

The city's utility posts record income thanks to rate hikes, funding massive green investments while navigating questions about cost and workplace safety.

A high-stakes legal battle unfolds as Xeris sues to block generic versions of its blockbuster Cushing's syndrome drug, Recorlev, until 2040.

Two memory giants are teaming up to standardize High Bandwidth Flash (HBF), a new memory tier aimed at solving AI's capacity and cost problems.

Strategic Storage Trust VI's new Toronto facility isn't just more space—it's a calculated response to the city's housing crunch and demographic boom.

Orion Group Holdings' strategic acquisition of J.E. McAmis, advised by ACT Capital, targets a booming infrastructure market with specialized expertise.

The Illinois-based bank crushed Q4 estimates with a 62.5% profit jump, outperforming sector trends through strong interest income and strategic growth.

A new report reveals nearly 8,000 documented fixes in seafood operations, from worker safety to animal welfare, driven by market demand for accountability.

High Liner Foods posts higher Q4 sales but faces shrinking profits from tariffs and acquisition costs. Can new products and efficiencies turn the tide?

Cannes Grand Prix winner Justin Kramm launches a new agency, betting that human-led comedy and storytelling will triumph over AI in the marketing world.

Morgan Stanley Direct Lending Fund reports lower Q4 NII and cuts its dividend, while launching a new joint venture to spur long-term strategic growth.

A go-kart empire's philanthropic efforts, fueled by its elderly dog mascot, result in a nearly quarter-million-dollar donation to animal shelters.

Surpassing $2B in sales and achieving sustained profitability, The RealReal's 2025 results signal a new era for the luxury resale giant. But can it last?

MidCap Financial adjusts its dividend and launches a massive $100M stock repurchase plan, aiming to boost value as its net asset value faces pressure.

Oportun celebrates a major financial turnaround and its fifth straight profitable quarter, but a closer look reveals rising delinquencies and new headwinds.

In a fragmented market, TraineryHCM's new certification from Brandon Hall Group highlights a growing demand for integrated HR platforms.

One in 10 Canadians has kidney disease, often with no symptoms. Experts urge immediate action as this silent crisis strains lives and our healthcare system.

The safety solutions leader adds a top CFO and CEO to its board, a strategic move to bolster financial oversight and drive growth amid record performance.

Neurizon Therapeutics has started dosing its promising ALS drug, NUZ-001, in the groundbreaking HEALEY Platform Trial, a pivotal step for patients.

The 3M spin-off navigates a transformative year, posting strong organic growth driven by MedSurg and Dental, despite a reported sales dip from divestitures.

FTAI Infrastructure's aggressive acquisitions drove an 82% jump in adjusted earnings, but hefty debt and transaction costs led to a significant net loss.